1
Clinical Trials associated with EH-002 / RecruitingNot ApplicableIIT A Study on the Safety, Tolerability, and Preliminary Efficacy of EH002 in the Treatment of DFNB9 Congenital Deafness
The study is designed to evaluate the safety, tolerability, and preliminary efficacy of EH002 for the treatment of congenital deafness caused by mutations in the OTOF gene. Participants may receive one or two injections of the EH002 gene therapy in one or both ears.
100 Clinical Results associated with EH-002
100 Translational Medicine associated with EH-002
100 Patents (Medical) associated with EH-002
100 Deals associated with EH-002